Literature DB >> 7689382

Non-dystrophic myotonias and periodic paralyses. A European Neuromuscular Center Workshop held 4-6 October 1992, Ulm, Germany.

F Lehmann-Horn1, R Rüdel, K Ricker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7689382     DOI： 10.1016/0960-8966(93)90009-9

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  12 in total

1.  A double mutation in families with periodic paralysis defines new aspects of sodium channel slow inactivation.

Authors:  S Bendahhou; T R Cummins; A F Hahn; S Langlois; S G Waxman; L J Ptácek
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Slow inactivation differs among mutant Na channels associated with myotonia and periodic paralysis.

Authors:  L J Hayward; R H Brown; S C Cannon
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

3.  Enhanced slow inactivation of the human skeletal muscle sodium channel causing normokalemic periodic paralysis.

Authors:  Lei Wu; Baorong Zhang; Ying Kang; Weiping Wu
Journal:  Cell Mol Neurobiol       Date:  2014-03-29       Impact factor: 5.046

4.  Modification of the Na+ current conducted by the rat skeletal muscle alpha subunit by coexpression with a human brain beta subunit.

Authors:  S C Cannon; A I McClatchey; J F Gusella
Journal:  Pflugers Arch       Date:  1993-04       Impact factor: 3.657

5.  N1366S mutation of human skeletal muscle sodium channel causes paramyotonia congenita.

Authors:  Qing Ke; Jia Ye; Siyang Tang; Jin Wang; Benyan Luo; Fang Ji; Xu Zhang; Ye Yu; Xiaoyang Cheng; Yuezhou Li
Journal:  J Physiol       Date:  2017-10-15       Impact factor: 5.182

6.  Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome.

Authors:  W David Arnold; Daniel H Feldman; Sandra Ramirez; Liuyuan He; Darine Kassar; Adam Quick; Tara L Klassen; Marian Lara; Joanna Nguyen; John T Kissel; Christoph Lossin; Ricardo A Maselli
Journal:  Ann Neurol       Date:  2015-03-27       Impact factor: 10.422

7.  Functional expression of the Ile693Thr Na+ channel mutation associated with paramyotonia congenita in a human cell line.

Authors:  E Plassart-Schiess; L Lhuillier; A L George; B Fontaine; N Tabti
Journal:  J Physiol       Date:  1998-03-15       Impact factor: 5.182

8.  Mechanisms underlying a life-threatening skeletal muscle Na+ channel disorder.

Authors:  Dina Simkin; Isabelle Léna; Pierre Landrieu; Laurence Lion-François; Damien Sternberg; Bertrand Fontaine; Saïd Bendahhou
Journal:  J Physiol       Date:  2011-04-26       Impact factor: 5.182

Review 9.  Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

10.  Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis.

Authors:  Valeria A Sansone; James Burge; Michael P McDermott; Patty C Smith; Barbara Herr; Rabi Tawil; Shree Pandya; John Kissel; Emma Ciafaloni; Perry Shieh; Jeffrey W Ralph; Antony Amato; Steve C Cannon; Jaya Trivedi; Richard Barohn; Brian Crum; Hiroshi Mitsumoto; Alan Pestronk; Giovanni Meola; Robin Conwit; Michael G Hanna; Robert C Griggs
Journal:  Neurology       Date:  2016-02-10       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.